All In MedTech

Device Trial Radar · NCT01526681

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

A Multicenter, Registry Study of Avance® Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair

Last checked: Nov 19, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

3,126

Actual

Start

Nov 2008

Primary completion

Nov 2028

Study completion Nov 2028

Sponsor

Lead sponsor
Axogen CorporationNot on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2012

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.

Conditions

  • Peripheral Nerve Injuries

Interventions

  • Processed Human Nerve GraftOther

    Implantation of appropriate length of processed human nerve graft at the time of surgery

  • Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.Other

    Historical control from established literature

  • Autogenous Nerve GraftOther

    Nerve gap reconstructions with autogenous nerve graft within the upper extremity

  • Nerve Tube ConduitDevice

    Nerve gap reconstructions with nerve tube conduit within the upper extremity

  • Autologous Breast Reconstruction with NeurotizationProcedure

  • Autologous Breast Reconstruction without NeurotizationProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Avance Nerve Graft: Incidence of Avance Nerve Graft Related Adverse EventsTime frame: Through study completion or until lost to follow-up, approximately 3 years
  2. RANGER and MATCH: Sensory Function as measured by Medical Research Council Classification (MRCC) for sensory recoveryTime frame: Through study completion or until lost to follow-up, approximately 3 years
  3. RANGER and MATCH: Motor Function as measured by Medical Research Council Classification (MRCC) for motor recoveryTime frame: Through study completion or until lost to follow-up, approximately 3 years

3 more outcomes with a free account

Locations

49 sites in 4 countries. Site status is shown where the registry gives one.

  • RANGER & MATCH: Arizona Center for Hand Surgery

    Phoenix, Arizona

  • RANGER: Phoenix Children's Hospital

    Phoenix, Arizona

  • RANGER & MATCH: University of California - Irvine

    Orange, California

46 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.